- Home
- UNCY vs LANV Comparison
UNCY vs LANV Comparison
Compare UNCY & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNCY | LANV |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.6M | 115.8M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | UNCY | LANV |
|---|---|---|
| Price | $3.50 | $0.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $28.40 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 14.7K |
| Earning Date | 11-16-2026 | 08-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10,044.55 | $3.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $0.75 |
| 52 Week High | $8.74 | $2.31 |
Technical Indicators
Market Signals| Indicator | UNCY | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 34.90 | 35.32 |
| Support Level | $3.35 | N/A |
| Resistance Level | $4.18 | $1.13 |
| Average True Range (ATR) | 0.26 | 0.05 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 19.42 | 23.53 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the St. John segment.